Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MLYS
MLYS logo

MLYS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MLYS News

Mineralys Reports Positive Clinical Data for Lorundrostat in Heart Failure Risk

6d agoNASDAQ.COM

Lorundrostat Significantly Reduces Heart Failure Risk Biomarkers

Jun 14 2026Newsfilter

Mineralys Therapeutics Prices Stock Offering at $26.50

Jun 03 2026seekingalpha

Mineralys Therapeutics Prices $150 Million Underwritten Offering

Jun 03 2026Newsfilter

Velan Capital Reduces Stake in Mineralys Therapeutics

May 31 2026NASDAQ.COM

Velan Capital Reduces Stake in Mineralys Therapeutics

May 31 2026Fool

Lorundrostat Shows Significant Efficacy in Chronic Kidney Disease Patients

May 30 2026Newsfilter

Mineralys Therapeutics Q1 2026 Earnings Call Highlights

May 07 2026seekingalpha

MLYS Events

06/14 17:00
Mineralys Therapeutics Presents New Data on Lorundrostat Heart Failure Risk Biomarkers
Mineralys Therapeutics presented new data on the effect of lorundrostat on heart failure risk biomarkers. This post hoc analysis of circulating proteomic data from participants enrolled in the Company's Launch-HTN and Advance-HTN trials was presented in a late-breaking poster presentation at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Illinois. "People with uncontrolled hypertension are at particular risk of heart failure, a condition where more effective treatments are still neededi," said Jon Congleton, Chief Executive Officer of Mineralys Therapeutics. "Aldosterone plays a well-established roleii in driving this disease, and these findings suggest that lorundrostat may act on the biological processes that contribute to heart failure, supporting further evaluation of its therapeutic potential in this setting."
06/03 16:40
Dow Falls 620.72 Points, Nasdaq Drops 239.92 Points
The major averages closed broadly lower as investors digested stronger-than-expected employment data from ADP ahead of Friday's official nonfarm payrolls report. In central bank news, the Federal Reserve said in its Beige Book that economic activity inccreased at a "slight to moderate pace," adding that employment showed little to no change across eleven Fed Districts. Meanwhile, oil prices rose once again amid continued tensions in the Middle East.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Elon Musk's SpaceXis targeting a $75B IPO with a $135 per share price,Alphabetis upsizing itsto $84.75B and reported that its Gemini app has 900M monthly users as of MayPalo Alto Networksprovided areport for Q3GameStopreported a year-over-year increase in earnings and revenue andMacy'sprovided areport for Q12. WALL STREET CALLS:Yum! Brandsto Overweight at Morgan StanleyConcurrently, Morgan StanleyChipotleto Equal WeightOppenheimerAT&Tto Perform, sees broadband subscribers at riskBernsteinCampbell's, Conagra Brands, General Mills, and Kraft Heinzto UnderperformRaymond Jamescoverage of FedEx Freightwith an Outperform rating3. AROUND THE WEB:Disneyhas sold a significant portion of Super Bowl LXI ad inventory at around $8M per 30-second spot after initially seeking higher pricing, following advertiser pushback, Variety reportsMetalost its appeal against the EU's designation of Messenger as a "gatekeeper" under the Digital Markets Act, meaning it will remain subject to stricter regulatory obligations, Reuters saysStripe, Visa, and MasterCardare nearing the launch of a stablecoin platform, with Coinbasealso exploring participation, CoinDesk reportsNestleis buying out the founders of yfood Labs for an undisclosed sum, Bloomberg saysThe antitrust division of the New York Attorney General's office is investigating Compass'footprint in the New York market, The Real Deal reports4. MOVERS:Navitasgained afterits 800 V-to-6 V DC-DC power delivery board is being shown at Nvidia'sshowcaseMaxLinearincreased after announcing a collaboration withCognytefell in New York afterand providing guidance for FY27Mineralyswas lower after announcing it willdue to Tanabe Pharma Corporation related to lorundrostatIntuitive Machinesdeclined afterof common stock5. EARNINGS/GUIDANCE:Thor Industriesand cut its guidance for FY26Medtronic, with EPS in-line with consensusOllie's Bargain Outlet, with CEO Eric van der Valk "very pleased" with the first quarter resultsSprinklrand provided its outlook for Q2 and FY27Scotts Miracle-Grobacked itsINDEXES:The Dow fell 620.72, or 1.21%, to 50,687.07, the Nasdaq lost 239.92, or 0.89%, to 26,853.98, and the S&P 500 declined 56.10, or 0.74%, to 7,553.68.
06/03 12:10
Mineralys Therapeutics Stock Down 17.1% to $23.92
Mineralys Therapeutics is down -17.1%, or -$4.93 to $23.92.
06/03 12:00
Major Averages Decline as Employment Data Surprises
The major averages were broadly lower near noon as investors digest stronger-than-expected employment data and wait for Friday's official nonfarm payrolls report. According to ADP, private-sector employers added 122,000 jobs in May, above the consensus forecast of 118,000 and up from the prior month's reading.Enthusiasm surrounding data-center spending, cloud infrastructure, semiconductors, and power-demand beneficiaries continues to support the broader indexes. However, investors have become increasingly selective, rewarding companies that can demonstrate tangible AI-related revenue growth while showing less patience for firms that are merely associated with the theme. Meanwhile, oil prices are higher once again amid continued tensions in the Middle East.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Elon Musk's SpaceXis targeting a $75B IPO with a $135 per share price,Alphabetisto $84.75B and reported that its Gemini app has 900M monthly users as of MayPalo Alto Networksprovided areport for Q3GameStopreported a year-over-year increase in earnings and revenue andMacy'sprovided areport for Q12. WALL STREET CALLS:Yum! Brandsto Overweight at Morgan StanleyConcurrently, Morgan StanleyChipotleto Equal WeightOppenheimerAT&Tto Perform, sees broadband subscribers at riskBernsteinCampbell's, Conagra Brands, General Mills, and Kraft Heinzto UnderperformRaymond Jamesof FedEx Freightwith an Outperform rating3. AROUND THE WEB:Metalost its appeal against the EU's designation of Messenger as a "gatekeeper" under the Digital Markets Act, meaning it will remain subject to stricter regulatory obligations, Reuters saysStripe, Visa, and MasterCardare nearing the launch of a stablecoin platform, with Coinbasealso exploring participation, CoinDesk reportsNestleis buying out the founders of yfood Labs for an undisclosed sum, Bloomberg saysThe antitrust division of the New York Attorney General's office is investigating Compass'footprint in the New York market, The Real Deal reportsDeutsche Bankmay set aside more for loan losses, Bloomberg says4. MOVERS:Navitasgains after reporting its 800 V-to-6 V DC-DCis being shown at Nvidia'sshowcaseMaxLinearincreases afterwith Los Alamos National LaboratoryCognytefalls in New York afterand providing guidance for FY27Mineralyslower after announcing it willdue to Tanabe Pharma Corporation related to lorundrostatIntuitive Machinesdeclines afterof common stock5. EARNINGS/GUIDANCE:Thor Industriesand cut its guidance for FY26Medtronic, with EPS in-line with consensusOllie's Bargain Outlet, with CEO Eric van der Valk "very pleased" with the first quarter resultsSprinklrand provided its outlook for Q2 and FY27Scotts Miracle-Grofor FY26INDEXES:Near midday, the Dow was down 0.88%, or 451.06, to 50,856.73, the Nasdaq was down 0.77%, or 209.30, to 26,884.60, and the S&P 500 was down 0.55%, or 42.14, to 7,567.64.

MLYS Monitor News

Mineralys Therapeutics Prices $150 Million Stock Offering

Jun 05 2026

Mineralys Therapeutics Prices $150 Million Stock Offering

Jun 03 2026

MLYS.O Falls Below 20-Day SMA Amid Bearish Sentiment

Nov 14 2025

MLYS Earnings Analysis

No Data

No Data

People Also Watch